Clinical Trials Logo

Awake Fiberoptic Intubation clinical trials

View clinical trials related to Awake Fiberoptic Intubation.

Filter by:
  • None
  • Page 1

NCT ID: NCT05736198 Not yet recruiting - Difficult Airway Clinical Trials

Comparison of Two Sedation Regimens for Awake Fiberoptic Intubation

Start date: June 12, 2023
Phase:
Study type: Observational

The purpose of this study is to examine the effects of different sedation drugs used for the awake fiberoptic intubation procedure. Benzodiazapines and narcotics (such as midazolam and fentanyl) are standard drugs used for sedation during awake fiberoptic intubation. Dexmedetomidine, midazolam, and fentanyl are approved by the Food and Drug Administration (FDA) procedural sedation. These drugs might be given to the patient regardless of their participation in the study. In addition to midazolam and fentanyl study subjects will also receive either dexmedetomidine or a placebo (a salt solution that contains no drug). It is believed that dexmedetomidine will not slow down breathing as much as the combination of the valium-like drug and narcotic. In our study, we are trying to determine if this is the best drug for sedation during an awake fiberoptic procedure.

NCT ID: NCT05320731 Recruiting - Clinical trials for Awake Fiberoptic Intubation

Atomization vs. Nebulization for Airway Topicalization During Awake Nasotracheal Fiberoptic Intubation

Start date: February 20, 2022
Phase: N/A
Study type: Interventional

Intubation of difficult airway is a challenge for anesthetist. There many causes of difficult airway, and previous studies concluded that awake fiber-optic intubation (AFOI) is the gold standard for the management of these patients. Several studies showed that airway nerve blocks provide rapid and deep airway anesthesia, however, due to their several disadvantages, topicalization of the airway represents a promising alternative to them. Some studies revealed that nebulization and atomization of the airway provide adequate anesthesia for AFOI. In the present study, we try to find out which is more effective for topicalization of the airway during nasotracheal AFOI; nebulization or atomization. We used a simple atomization device as a modification of the McKenzie technique.

NCT ID: NCT01995292 Completed - Clinical trials for Awake Fiberoptic Intubation

Comparison of Two Different Types of "Spray as You go" Technique for Awake Fiberoptic Intubation

Start date: October 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether modified "spray as you go" technique using the Enk Fiberoptic Atomizer Set during awake fiberoptic intubation is more comfortable for the patient.

NCT ID: NCT00383890 Completed - Clinical trials for Awake Fiberoptic Intubation

A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation for Elective Awake Fiberoptic Intubation

Start date: August 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of dexmedetomidine versus placebo used for sedation during elective awake fiberoptic intubation.